Melatonin per Sleep-Related Cognitive Impairment

Q: Does Melatonin help with Sleep-Related Cognitive Impairment?

Based on 15 studies with 2,000 participants, there is limited but promising evidence that Melatonin may support Sleep-Related Cognitive Impairment management. Our evidence grade is C (Some Evidence).

Q: How much Melatonin should I take for Sleep-Related Cognitive Impairment?

Studies have used various dosages. A commonly studied range is 0.5-5 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Melatonin?

Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Melatonin and Sleep-Related Cognitive Impairment?

We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dsleep\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

In sintesi

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

Key Study Findings

review

Pediatric Insomnia.

Dose: Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) vs: Placebo Effetto: CBT-I most effective treatment; melatonin beneficial in children with ASD or ADHD; limited evidence None

Other

Banxia Shumi Decoction Improves Sleep and Neural Function in Insomnia Male Rats via BDNF/TrkB/CREB-Dependent Melatonin …

Dose: None vs: PCPA-induced insomnia model control Outcome: Sleep quality and cognitive function in rat model Effetto: None None

Popolazione: PCPA-induced insomnia male rats

Randomized Controlled Trial n=322 5 weeks Double-blind

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, …

Dose: 20 mg or 50 mg tasimelteon daily vs: Placebo Outcome: Latency to persistent sleep (PSG) Effetto: -44.9 min (20mg) / -46.3 min (50mg) vs -28.2 (placebo) <0.001

Popolazione: Patients with primary insomnia (sleep onset difficulty)

Review

Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.

Dose: None vs: None Outcome: ISWRD symptom management Effetto: None None

Popolazione: Patients with irregular sleep-wake rhythm disorder

review

Insomnia in older adults: A review of treatment options.

Dose: various vs: Placebo Effetto: None None

Review

Commonly encountered symptoms and their management in patients with cirrhosis.

Dose: None vs: None Outcome: Pain outcomes Effetto: None None

Popolazione: Insomnia patients

Key Statistics

Studi

2000

Partecipanti

↑

Positive

Grado

Referenced Papers

Pediatric Insomnia. Review

Pediatrics in review 2026

Insomnia in older adults: A review of treatment options. Review

Cleveland Clinic journal … 2025 12 citazioni

Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment. Review

Handbook of clinical … 2025 4 citazioni

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial. RCT

PloS one 2025 1 citazioni

Banxia Shumi Decoction Improves Sleep and Neural Function in Insomnia Male Rats via BDNF/TrkB/CREB-Dependent Melatonin Signaling Activation. Other

Neurochemical research 2025

Interventions for insomnia in cancer patients and survivors-a comprehensive systematic review and meta-analysis. Meta-Analysis

JNCI cancer spectrum 2024 24 citazioni

Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus Group. Review

Journal of neurology 2024 21 citazioni

Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Serotonin Receptor Activity in a Murine Model. Other

Antioxidants (Basel, Switzerland) 2024 17 citazioni

Delayed sleep wake phase disorder in adolescents: an updated review. Review

Current opinion in … 2024 12 citazioni

Commonly encountered symptoms and their management in patients with cirrhosis. Review

Frontiers in medicine 2024 4 citazioni

[Pharmacotherapies for insomnia]. Other

La Revue du … 2024

Complementary and alternative treatments for insomnia disorder: a systematic umbrella review. Systematic Review

Journal of sleep … 2023 12 citazioni

RP58 knockdown contributes to hypoxia-ischemia-induced pineal dysfunction and circadian rhythm disruption in neonatal rats. Other

Journal of pineal … 2023 7 citazioni

Targeting neuroendocrine abnormalities in Parkinson's disease with exercise. Other

Frontiers in neuroscience 2023 5 citazioni

The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease. Review

Current drug safety 2023 2 citazioni

Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial. Other

BMJ open 2022 3 citazioni

Melatonin ameliorates Parkinson's disease via regulating microglia polarization in a RORα-dependent pathway. Other

NPJ Parkinson's disease 2022

Biological rhythms and chronotherapeutics in depression. Review

Progress in neuro-psychopharmacology … 2021 68 citazioni

Circadian Rhythm Disorders and Corresponding Functional Brain Abnormalities in Young Female Nurses: A Preliminary Study. Other

Frontiers in neurology 2021 16 citazioni

A Systematic Review of the Efficacy and Safety of Over-the-Counter Medications Used in Older People for the Treatment of Primary … Systematic Review

The Senior care … 2021 12 citazioni

The role of pineal microRNA-325 in regulating circadian rhythms after neonatal hypoxic-ischemic brain damage. Other

Neural regeneration research 2021 6 citazioni

Insomnia and menopause: a narrative review on mechanisms and treatments. Review

Climacteric : the … 2020 97 citazioni

Sleep Issues in Parkinson's Disease and Their Management. Review

Neurotherapeutics : the … 2020 80 citazioni

Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease. Review

Current treatment options … 2020 29 citazioni

The effect of jet lag on the human brain: A neuroimaging study. Other

Human brain mapping 2020 15 citazioni

Clinical Pearls on Sleep Management in Atopic Dermatitis. Review

Dermatitis : contact, … 2019 7 citazioni

European guideline for the diagnosis and treatment of insomnia. Other

Journal of sleep … 2017 1691 citazioni

A review of sleep disorders and melatonin. Review

Neurological research 2017 331 citazioni

Dietary Sources and Bioactivities of Melatonin. Review

Nutrients 2017 301 citazioni

Treatment of Sleep Dysfunction in Parkinson's Disease. Review

Current treatment options … 2017 56 citazioni

Melatonin restores hippocampal neural precursor cell proliferation and prevents cognitive deficits induced by jet lag simulation in adult mice. Other

Journal of pineal … 2017 45 citazioni

Review of Safety and Efficacy of Sleep Medicines in Older Adults. Review

Clinical therapeutics 2016 328 citazioni

Pediatric Insomnia. Review

Chest 2016 109 citazioni

Melatonin has multiorgan effects. Review

European heart journal. … 2016 77 citazioni

Keeping circadian time with hormones. Review

Diabetes, obesity & … 2015 132 citazioni

Assessment and treatment of insomnia in adult patients with alcohol use disorders. Review

Alcohol (Fayetteville, N.Y.) 2015 122 citazioni

Treatment of chronic insomnia disorder in menopause: evaluation of literature. Review

Menopause (New York, … 2015 73 citazioni

Air travel: effects of sleep deprivation and jet lag. Review

Chest 2013 53 citazioni

Familial circadian rhythm disorder in the diurnal primate, Macaca mulatta. Other

PloS one 2012 14 citazioni

Melatonin in experimental seizures and epilepsy. Review

Pharmacological reports : … 2011 99 citazioni

Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? Review

Progress in neuro-psychopharmacology … 2011 71 citazioni

[Insomnias. II. Pharmacological and psychotherapeutic treatment options]. Meta-Analysis

Der Nervenarzt 2009 6 citazioni

Therapeutic options for sleep-maintenance and sleep-onset insomnia. Review

Pharmacotherapy 2007 117 citazioni

[Rhythms, depressions and light]. Review

Tidsskrift for den … 2006

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Other

Brain research. Molecular … 2005 160 citazioni

Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Other

Reviews of reproduction 1998 381 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:: 0.5-5 mg/day
sleepcognitivesupport:: 0.5-3 mg 30-60 min before bed

Limite massimo: 10 mg/day (higher doses not more effective)

Dosaggi studiati nella ricerca

Dosaggio	Durata	Effetto	N
Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other)	--	Positive	--
None	--	Positive	--
20 mg or 50 mg tasimelteon daily	5 weeks	Positive	322
None	--	Mixed	--
various	--	Positive	--
None	--	Neutral	--
None	--	Positive	6528
Z-drugs, melatonin, orexin antagonists	--	Positive	--

Momento migliore per l'assunzione: 30-60 minutes before bedtime

Safety & Side Effects

Effetti collaterali segnalati

⚠ Daytime drowsiness
⚠ Headache
⚠ Dizziness
⚠ Nausea
⚠ Vivid dreams

Interazioni note

● Sedative medications (additive drowsiness)
● Blood thinners (may increase bleeding risk)
● Diabetes medications (may affect blood sugar)
● Immunosuppressants (may stimulate immune function)
● Oral contraceptives (may increase melatonin levels)

Livello di assunzione massimo tollerabile: 10 mg/day (higher doses not more effective)

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Melatonin help with Sleep-Related Cognitive Impairment?

Based on 15 studies with 2,000 participants, there is limited but promising evidence that Melatonin may support Sleep-Related Cognitive Impairment management. Our evidence grade is C (Some Evidence).

How much Melatonin should I take for Sleep-Related Cognitive Impairment?

Studies have used various dosages. A commonly studied range is 0.5-5 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Melatonin?

Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Melatonin and Sleep-Related Cognitive Impairment?

We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

Altri ingredienti per Sleep-Related Cognitive Impairment

Ashwagandha C L-Theanine C Magnesium L-Threonate C Creatine C

Verdetto rapido

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

Evidence Strength52%

Moderate confidence

Analisi degli studi

RCT (1)Meta (2)Other (12)

Confronta le alternative

Scoprite come si confrontano altri ingredienti per questa condizione.

Visualizza tutti gli ingredienti per Sleep-Related Cognitive Impairment

Approfondimenti

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.